Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
67.51%
↑ 195% above average
Average (8y)
-71.37%
Historical baseline
Range
High:67.51%
Low:-544.00%
Volatility
-856.8%
Relatively stable
| Period | Value |
|---|---|
| 2024 | 67.51% |
| 2023 | 16.20% |
| 2022 | 12.70% |
| 2021 | -183.72% |
| 2020 | 48.50% |
| 2019 | -107.45% |
| 2018 | -544.00% |
| 2017 | 47.92% |
| 2016 | 0.00% |